R. Faught

发表

Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging

R. Kuzniecky, J. Hugg, F. Gilliam, 1996, Annals of neurology.

Visual confrontation naming and hippocampal function: A neural network study using quantitative (1)H magnetic resonance spectroscopy.

R. Kuzniecky, B. Maton, J. Hugg, 2000, Brain : a journal of neurology.

A neural network study using quantitative 1 H magnetic resonance spectroscopy

R. Kuzniecky, B. Maton, J. Hugg, 2000 .

Intravenous prostacyclin in acute nonhemorrhagic stroke: a placebo-controlled double-blind trial.

E. Hogan, R. Faught, C. Hsu, 1987, Stroke.

Efficacy of felbamate monotherapy in patients undergoing presurgical evaluation of partial seizures

B. Wilder, O. Devinsky, A. Kanner, 1995, Epilepsy Research.

Reversible Kernohan notch

R. Kuzniecky, B. Maton, J. Hugg, 2007, Neurology.

Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004 .

Kaplan–Meier analysis on seizure outcome after epilepsy surgery: Do gender and race influence it?

R. Kuzniecky, R. Knowlton, J. Burneo, 2008, Seizure.

Safety and Tolerability of Gabapentin as Adjunctive Therapy in a Large, Multicenter Study

G. Holmes, M. Morrell, M. Privitera, 1999, Epilepsia.

Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy

B. Bourgeois, W. Marks, J. Stern, 2004, Neurology.

Efficacy and Tolerability of the New Antiepileptic Drugs , II : Treatment of Refractory Epilepsy : Report of the TTA and QSS

B. Bourgeois, W. Marks, J. Stern, 2004 .

Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.

R. Kuzniecky, R. Knowlton, T. Welty, 2003, Archives of neurology.

Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators.

R. Adams, T. Feasby, P. Lyden, 1998, Stroke.

Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New‐Onset Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004, Epilepsia.

CME Efficacy and tolerability of the new antiepileptic drugs I : Treatment of new onset epilepsy Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004 .

The relationship of depression to antiepileptic drug adherence and quality of life in epilepsy

R. Faught, R. Manjunath, M. Good, 2014, Epilepsy & Behavior.

Efficacy of gabapentin as adjunctive therapy in a large, multicenter study

G. Holmes, M. Morrell, M. Privitera, 2000, Seizure.

Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy

B. Bourgeois, W. Marks, J. Stern, 2004, Neurology.

Long‐Term Experience with Topiramate as Adjunctive Therapy and as Monotherapy in Patients with Partial Onset Seizures: Retrospective Survey of Open‐Label Treatment

W. Rosenfeld, M. Privitera, R. Sachdeo, 1997, Epilepsia.

Teddy bears: An observational finding in patients with non-epileptic events

R. Knowlton, J. Burneo, R. Martin, 2003, Neurology.

Is the intracellular pH different from normal in the epileptic focus of patients with temporal lobe epilepsy?

D. Twieg, J. Hugg, R. Kuzniecky, 1996, Neurology.

Impact of nonadherence to antiepileptic drugs on health care utilization and costs: Findings from the RANSOM study

R. Faught, M. Cunnington, M. Duh, 2009, Epilepsia.

A comparison of physicians’ attitudes and beliefs regarding driving for persons with epilepsy

Roy C. Martin, R. Faught, L. Vogtle, 2007, Epilepsy & Behavior.

Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy

B. Bourgeois, W. Marks, J. Stern, 2004, Neurology.

In vivo hippocampal metabolic dysfunction in human temporal lobe epilepsy.

R. Kuzniecky, R. Knowlton, B. Abou-Khalil, 2002, Archives of neurology.

Interictal epileptiform discharge effects on neuropsychological assessment and epilepsy surgical planning

J. Ojemann, John W. Miller, D. Loring, 2016, Epilepsy & Behavior.

Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy

R. Kuzniecky, B. Maton, J. Hugg, 2007, Neurology.

Nonlinear Trends in Hippocampal Metabolic Function and Verbal Memory: Evidence of Cognitive Reserve in Temporal Lobe Epilepsy?

R. Kuzniecky, B. Maton, J. Hugg, 2000, Epilepsy & Behavior.

Cessation of gamma activity in the dorsomedial nucleus associated with loss of consciousness during focal seizures

K. Meador, R. Gross, O. Smart, 2015, Epilepsy & Behavior.

Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy. Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004 .

Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy

B. Bourgeois, W. Marks, J. Stern, 2004, Neurology.

Significance of interictal temporal lobe delta activity for localization of the primary epileptogenic region

R. Kuzniecky, F. Gilliam, E. Bilir, 1999, Neurology.

Research Demonstrating the Effects of Interictal Epileptiform Discharges on Cognition and Behavior

J. Ojemann, John W. Miller, D. Loring, 2022 .

B. Bourgeois, W. Marks, J. Stern, 2004 .

Appendix D: Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2007 .

Interictal epileptiform discharge effects on neuropsychological assessment and epilepsy surgical planning

J. Ojemann, John W. Miller, D. Loring, 2016, Epilepsy & Behavior.

Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004, Epilepsia.

CME Efficacy and tolerability of the new antiepileptic drugs II : Treatment of refractory epilepsy Report of the Therapeutics and Technology Assessment

G. Montouris, R. Sachdeo, R. Faught, 2004 .

CME Efficacy and tolerability of the new antiepileptic drugs I : Treatment of new onset epilepsy

B. Bourgeois, W. Marks, J. Stern, 2004 .